CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Coland Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Coland Holdings Ltd
2F
No. 380, Fenglin Road, Xuhui District
Phone: +86 2154681666p:+86 2154681666 Shanghai, SHA  201203  China Fax: +86 2151371882f:+86 2151371882
This company is no longer actively traded on any major stock exchange.
Business Summary
Coland Holdings Limited is a Taiwan-based company principally engaged in the development and distribution of pharmaceuticals. The Company provides products for the treatment of hepatitis, respiratory system diseases, urinary systems, cardiovascular and nervous system diseases. The Company also offers medical equipment, spinal instrumentations and antibiotics. Its products include Adefovir Dipivoxil Tablets, Mycophenolate Mofetil Dispersible Tablets, Tiotropium Bromide Powder For Inhalation, Amoxicillin Sodium and Clavulanate Potassium for Injection and Lamivudine Tablets. The Company operates its businesses primarily in Mainland China.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202012/31/2019Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
3842 Orthopedic, prosthetic, and surgical appliances and supplies
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board William R.Keller 72 12/5/2010 12/5/2010
Chief Financial Officer RuohuaCao 7/1/2008 7/1/2008
Chief Investment Officer QingqiZheng 2/1/2012 2/1/2012
8 additional Officers and Directors records available in full report.

Business Names
Business Name
4144
Central Chief Limited

General Information
Number of Employees: 305 (As of 12/31/2012)
Outstanding Shares: 77,139,000 (As of 6/30/2020)
Shareholders: 7,546
Stock Exchange: TPE
Fax Number: +86 2151371882


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024